Order Article Reprints

Zhao K, Braun M, Meyer L, Otte K, Raifer H, Helmprobst F, Möschl V, Pagenstecher A, Urban H, Ronellenfitsch MW, et al. A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells. 2024; 13(7):632. https://doi.org/10.3390/cells13070632

Zhao, Kai, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W. Ronellenfitsch, and et al. 2024. "A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1" Cells 13, no. 7: 632. https://doi.org/10.3390/cells13070632

Zhao, K., Braun, M., Meyer, L., Otte, K., Raifer, H., Helmprobst, F., Möschl, V., Pagenstecher, A., Urban, H., Ronellenfitsch, M. W., Steinbach, J. P., Pesek, J., Watzer, B., Nockher, W. A., Taudte, R. V., Neubauer, A., Nimsky, C., Bartsch, J. W., & Rusch, T. (2024). A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells, 13(7), 632. https://doi.org/10.3390/cells13070632